The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.
Afnan Tariq, MD, discusses early data on a passive, device-agnostic AI platform for heart failure monitoring. “When clinicians are empowered with insights and able to act earlier, you're able to have a durable impact," he said.
While the Trump administration is pushing to accelerate clinical AI adoption, SCAI has emphasized that physicians must guide how the technology is implemented and governed.
Leslee Shaw, PhD, director of The Blavatnik Family Women’s Health Research Institute, Mount Sinai Hospital, New York, explains how cardiac computed tomography (CT) can be used to assess coronary plaques.
Lisa Mead, PSO executive director, Strategic Radiology, spoke at the Radiology Business Management Association (RBMA) 2022 meeting on her organization's experience collaborating with a large number of radiology groups.
Siemens Healthineers showed examples at ACC 2022 of cardiac computed tomography (CT) from its new Naeotom Alpha photon-counting CT scanner cleared by the FDA in 2021.
Ami Bhatt, MD, the American College of Cardiology (ACC) chief innovation officer and adult congenital heart disease cardiologist at Mass General Hospital, discusses how to get physician acceptance to use artificial intelligence (AI).
The Medtronic Linq and Linq II implantable cardiac monitors (ICM) have become some of the most popular ICM devices on the market, partly because they are easy to insert.
